Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

163.46
-2.5900-1.56%
Volume:140.75K
Turnover:23.06M
Market Cap:9.78B
PE:-24.18
High:165.74
Open:164.72
Low:162.71
Close:166.05
Loading ...

Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

Benzinga
·
05 Nov 2024

Ascendis, Novo Nordisk to Develop, Commercialize Products in Metabolic, Cardiovascular Diseases

MT Newswires Live
·
05 Nov 2024

Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald

Dow Jones
·
04 Nov 2024

Ascendis Pharma (ASND) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
04 Nov 2024

Ascendis Pharma A/S expected to post a loss of €1.73 a share - Earnings Preview

Reuters
·
02 Nov 2024

BioMarin's Pipeline Faces Skepticism As Analyst Questions Future Growth

Benzinga
·
31 Oct 2024

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
29 Oct 2024

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
23 Oct 2024

Ascendis Pharma a/S : JP Morgan Cuts Target Price to $174 From $180

THOMSON REUTERS
·
23 Oct 2024

Morgan Stanley Reaffirms Their Hold Rating on Ascendis Pharma (ASND)

TIPRANKS
·
21 Oct 2024

European Equities Traded in the US as American Depositary Receipts Rise Friday

MT Newswires Live
·
18 Oct 2024

Ascendis Pharma ticks higher amid chatter it cancelled from upcoming conference

seekingalpha
·
17 Oct 2024

Ascendis Pharma (ASND) Receives a Hold from Morgan Stanley

TIPRANKS
·
14 Oct 2024

Ascendis Pharma Updates Corporate Charter and Capital Structure

TIPRANKS
·
10 Oct 2024

RA Capital Management, L.P. Acquires New Stake in Bioage Labs Inc

GuruFocus.com
·
08 Oct 2024

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.
·
01 Oct 2024